Prognostic value of C-reactive protein in patients with COVID-19
Xiaomin Luo(Wuhan University), Weize Yang(Wuhan University), Hongxia Xia(Wuhan University), Benchao Wang(Wuhan University), Xiaojie Yan(Wuhan University), Wei Zhou(Children's Hospital of Fudan University), Tangxi Guo(Wuhan University), Lu Ye(Wuhan University), Yu Liu(Wuhan University), Zongping Jiang(Wuhan University), Jun Xiong(Wuhan University), Bicheng Zhang(University of Electronic Science and Technology of China)
Cited by 120
Related Papers
Clinical characteristics of 82 cases of death from COVID-19
|PLoS ONE|2020|594
Immune Phenotyping Based on the Neutrophil-to-Lymphocyte Ratio and IgG Level Predicts Disease Severity and Outcome for Patients With COVID-19
|Frontiers in Molecular Biosciences|2020|497
Prognostic Value of C-Reactive Protein in Patients With Coronavirus 2019
|Clinical Infectious Diseases|2020|458
Chinese expert consensus on the perinatal and neonatal management for the prevention and control of the 2019 novel coronavirus infection (First edition)
|Annals of Translational Medicine|2020|357
Anti-angiogenic Agents in Combination With Immune Checkpoint Inhibitors: A Promising Strategy for Cancer Treatment
|Frontiers in Immunology|2020|256